patients with suspicion of having cACLD as assessed by transabdominal ultrasound, laboratory findings, FIB-4 and/or APRI score, and/or LS measurements
patients with chronic liver disease in whom any extrahepatic surgical procedure is planned and in whom it was not possible to exclude cACLD and/or portal hypertension based on non-invasive procedures only
patients with HCC or other liver tumors on the ground of presumed liver cirrhosis who are under consideration for surgical resection, in whom HVPG is performed in order to reliably exclude clinically significant portal hypertension
compliance to the study protocol
signed approval for the diagnostic ultrasound with SWE™ and for transjugular liver biopsy and HVPG measurement
You may not be if
elevated alanine aminotransferase (ALT) values \> 5 x upper limit of normal (ULN)
